Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Hartford Post.
Press releases published on August 1, 2025

Malcolm Muusic’s ‘Down is Up’ Fuses 10-Track Gospel Album, Book, and Merch Into an Award-Worthy project.
A multi-sensory gospel experience that blends storytelling, faith, and fashion—earning praise from Connecticut creatives and award buzz nationwide. HARTFORD, CT, UNITED STATES, August 1, 2025 /EINPresswire.com/ -- The Langu LLC Email: [ contact@ …

Glastonbury Professionals House Painters Recognized as the Best in Glastonbury, CT, and Surrounding Areas
Glastonbury Professionals House Painters has been named one of the best painting companies in Glastonbury, CT. GLASTONBURY, CT, UNITED STATES, August 1, 2025 /EINPresswire.com/ -- Glastonbury Professionals House Painters is proud to be recognized as one …

Fairfield Painting Contractors Recognized as Leading House Painters in Fairfield, CT, Celebrating 20 Years of Excellence
Fairfield Painting Contractors has been a trusted name in residential painting throughout Fairfield, CT, for decades. FAIRFIELD, CT, UNITED STATES, August 1, 2025 /EINPresswire.com/ -- Fairfield Painting Contractors is proudly celebrating 20 years as …

Hudson RPO Announces Strategic Integration of CMRG to Expand Employer Branding and Talent Engagement Capabilities
OLD GREENWICH, Conn., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (the “Company” or “Hudson RPO”) (Nasdaq: HSON), a leading global total talent solutions company, announced today the strategic integration of McKinsey CMO Group (“CMRG”), a …

Oxford Square Capital Corp. Prices Public Offering of $65 Million 7.75% Notes Due 2030
GREENWICH, Conn., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQG) (NasdaqGS: OXSQZ) (the “Company”) today announced that it has priced an underwritten public offering of $65 million in aggregate principal …

BioXcel Therapeutics Announces Last Patient Last Visit in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
Vast majority of patients dosed completed the full 12-week study Data from more than 2,200 agitation episodes collected Topline data readout anticipated this month NEW HAVEN, Conn., Aug. 01, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI …

HCM III Acquisition Corp. Announces Pricing of $220 Million Initial Public Offering
STAMFORD, CT, July 31, 2025 (GLOBE NEWSWIRE) -- HCM III Acquisition Corp. (the “Company”), a blank check company whose business purpose is to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar …